The slip
PARKINSON RECEIPTno. 7297
23 Oct 2026, 07:06 UTCdopamine neurons, braak
predictionMEF2C in dopamine neurons tracks Braak Lewy-body stage
registered7c2621251defb62b
discovery+0.07 p=0.855 n=9
replication-0.06 p=0.874 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.07, p 0.855)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTb13741268e64ab140629efdf…
follows c2d1e35bb763…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7297: MEF2C in dopamine neurons, braak
- power
- full sample +0.06 (p 0.807, n 18), 95% CI -0.42 to +0.51. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.840, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.09 (p 0.715, n 18). could be the mix.
- skeptic
- leave-one-out range -0.02 to +0.22, sign flips 2; without severely affected donors +0.06 (p 0.807, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MEF2C in dopamine neurons.
case closed: nothing better to follow up.